Abstract
The nitrogen-containing bisphosphonates used for management of the patients with osteoporosis were reported to influence the function of renal tubular cells. However, how nitrogen-containing bisphosphates exert any effects on ion currents remains controversial. The effects of ibandronate (Iban), a nitrogen-containing bisphosphonate, on ionic channels, including two types of Ca2+-activated K+ (KCa) channels, namely, large-conductance KCa (BKCa) and intermediate-conductance KCa (IKCa) channels, were investigated in Madin–Darby canine kidney (MDCK) cells. In whole-cell current recordings, Iban suppressed the amplitude of voltage-gated K+ current elicited by long ramp pulse. Addition of Iban caused a reduction of BKCa channels accompanied by a right shift in the activation curve of BKCa channels, despite no change in single-channel conductance. Ca2+ sensitivity of these channels was modified in the presence of this compound; however, the magnitude of Iban-mediated decrease in BKCa-channel activity under membrane stretch with different negative pressure remained unchanged. Iban suppressed the probability of BKCa-channel openings linked primarily to a shortening in the slow component of mean open time in these channels. The dissociation constant needed for Iban-mediated suppression of mean open time in MDCK cells was 12.2 μM. Additionally, cell exposure to Iban suppressed the activity of IKCa channels, and DC-EBIO or 9-phenanthrol effectively reversed its suppression. Under current-clamp configuration, Iban depolarized the cells and DC-EBIO or PF573228 reversed its depolarizing effect. Taken together, the inhibitory action of Iban on KCa-channel activity may contribute to the underlying mechanism of pharmacological or toxicological actions of Iban and its structurally similar bisphosphonates on renal tubular cells occurring in vivo.
Abbreviations: BKCa channel, large-conductance Ca2+-activated K+ channel; [Ca2+]i, intracellular Ca2+ concentration; DC-EBIO, 5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one; DMEM, Dulbecco’s modified Eagle’s medium; FBS, fetal bovine serum; H2S, hydrogen sulfide; Iban, ibandronate sodium; IK, voltage-gated K+ current; IKCa channel, intermediate-conductance Ca2+-activated K+ channel; I–V, current–voltage; KCa channel, Ca2+-activated K+ channel; KD, dissociation constant; MDCK cell, Madin–Darby canine kidney cell,NaHS, sodium hydrosulphide; PF573228, 3,4-dihydro-6-[[4-[[[3-(methylsulfonyl)phenyl]methyl]amino]-5(trifluoromethyl)-2-pyrimidinyl]amino]-2(1H)-quinolinone; SEM, standard error of the mean; TRAM-34, 1-((2-chloropheny) (diphenyl)methyl)-1H-pyrazole
Keywords: Ibandronate, MDCK cell, Large-conductance Ca2+-activated K+ channel, Intermediate-conductance Ca2+-activated K+ channel, Membrane potential
1. Introduction
Bisphosphonates are recognized as stable analogs of pyrophosphates, which have been approved for treatment of postmenopausal osteoporosis [23]. These compounds are not metabolized in either man or animal, and consequently, they are the active, parent compounds. The principal route of their elimination results from renal excretion [15] and these compounds can accumulate in the kidney during therapy [3], [38]. It is important to note that potential nephrotoxicity has been observed in patients receiving high-dose bisphosphonate therapy, particularly when administrated by rapid intravenous administration [2], [18], [22], [27], [28], [29], [32]. The renal effects of these compounds were thought to be through a mechanism linked to their inhibition of farnesyl pyrophosphate synthase [19].
It has been demonstrated that intermittent treatment with ibandronate (Iban) or zoledronate, which is known to be a potent nitrogen-containing bisphosphonate, caused hypertrophy and hyperplasia of distal tubules and collecting ducts in the rats [29]. Alternatively, previous observations at our laboratory showed that iban was able to decrease the activity of IKCa channels in RAW 264.7 osteoclast precursor cells and that its block of these channels appeared to have a causal link to the inhibition of cell migration [45]. In contrast, another noteworthy study by Ma et al. [20] has demonstrated that zoledronate could activate the activity of BKCa channels in breast cancer cells and that such effect appeared to be responsible for the apoptotic change caused by this compound. However, the ionic mechanism of their actions on renal tubular cells remains largely elusive.
The BKCa channels (maxi-K, KCa1.1, KCNNMA1, Slo1) are products of a nearly ubiquitous, alternatively spliced gene. They possess the largest single-channel conductance of all K+ selective channels, which are synergistically activated by membrane depolarization and/or elevation of [Ca2+]i [43]. These pharmacologically promiscuous channels which can be stimulated by a chemically diverse range of small molecule drugs are functionally expressed in many cell types, including renal tubular cells [5], [17], [24], [37], [43], [44]. Of importance, these channels are localized in a variety of kidney cells, where they have important roles ranging from regulators of glomerular filtration to conduits for K+ secretion [17], [24], [40], [41]. However, how Iban can interact with these channels to perturb whole-cell currents or membrane potential is incompletely understood.
Previous studies have reported the important roles of KCa channels in kidney functions. For example, perfusion of isolated collecting ducts revealed that iberiotoxin, an inhibitor of BKCa channels, could inhibit K+ secretion during high tubular fluid flow [42]. Renal responsiveness to consumption of high K, alkaline diet was reported to be seriously impaired in BK-β4 knockout mice and their plasma K+ level was greatly elevated [9], [41]. Additionally, IKCa channels have been demonstrated to be strongly linked to diabetic nephropathy [10].
The Madin–Darby canine kidney (MDCK) renal tubular cell line has been a useful model for studies of functional activities existing in renal tubular cells [13], [14]. Therefore, to fill the knowledge gap, the goals of this study were (1) to investigate possible effects of Iban on macroscopic and single-channel currents and (2) to determine how it can interact with ion channels to modify membrane potential of MDCK cells. Besides its inhibition of farnesyl pyrophosphate synthase [19], the effects of Iban on ion channels shown in this study are obligate mechanisms by which it or its structurally similar bisphosphonates can influence the functional activities of renal tubular cells, if similar findings occur in vivo.
2. Materials and methods
2.1. Drugs and solutions
Ibandronate sodium (Iban; C9H22NO7P2Na · H2O; Bonviva®) was obtained from Hoffmann-La Roche Ltd. (Basel, Switzerland), (±)-ketamine was from Cerilliant Corp. (Round Rock, TX), paxilline was from Alomone Labs (Jerusalem, Israel), ionomycin, oxalate (ethanedioate) and sodium hydrosulphide (NaHS) were from Sigma–Aldrich Inc. (St. Louis, MO), DC-EBIO (i.e., 5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one), and 9-phenanthrol, PF573228 (i.e., 3,4-dihydro-6-[[4-[[[3-(methylsulfonyl) phenyl]methyl]amino]-5(trifluoromethyl)-2-pyrimidinyl]amino]-2(1H)-quinolinone) and TRAM-34 (i.e., 1-((2-chloropheny) (diphenyl) methyl)-1H-pyrazole) were from Tocris (Bristol, UK). Chlorotoxin was kindly provided by Dr. Woei-Jer Chuang (Department of Biochemistry, National Cheng Kung University Medical College, Tainan City, Taiwan). All culture media, FBS, l-glutamine, penicillin-streptomycin, fungizone and trypsin/EDTA were obtained from Invitrogen (Carlsbad, CA). All other chemicals were commercially available and of reagent grade. Twice-distilled water was de-ionized through a Milli-Q water purification system (APS Water Services Inc., Van Nuys, CA).
The composition of the bathing solution (i.e., normal Tyrode’s solution) was 136.5 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 0.53 mM MgCl2, 5.5 mM glucose, and 5.5 mM HEPES-KOH buffer, pH 7.4. To measure K+ currents or membrane potential in MDCK cells, the patch pipette was filled with a solution consisting of 130 mM K-aspartate, 20 mM KCl, 1 mM KH2PO4, 1 mM MgCl2, 3 mM Na2ATP, 0.1 mM Na2GTP, 0.1 mM EGTA, and 5 mM HEPES-KOH buffer, pH 7.2.
For the recordings of BKCa-channel activity, high K+-bathing solution contained 145 mM KCl, 0.53 mM MgCl2, and 5 mM HEPES-KOH buffer (pH 7.4), and the pipette solution contained 145 mM KCl, 2 mM MgCl2, and 5 mM HEPES-KOH (pH 7.2). The free Ca2+ concentration was calculated assuming a dissociation constant of 0.1 mM for EGTA and Ca2+ (at pH 7.2) (http://maxchelator.stanford.edu/CaEGTA-TS.htm).
2.2. Cell preparation
The MDCK cell line (BCRC-60004), a canine renal tubular cell line, was obtained from Bioresource Collection and Research Center (Hsinchu, Taiwan). Cells were routinely cultured in DMEM supplemented with 10% heat-inactivated FBS, 100 U/ml penicillin and 100 μg/ml streptomycin at 37 °C in 5% CO2-containing humidified air [13]. Culture medium was continuously replaced every 2 days to maintain a healthy cell population. For long-term storage, the cells were frozen in DMEM containing 10% dimethyl sulfoxide, and kept in liquid nitrogen. Prior to their use in electrophysiological experiments, cells were grown on glass coverslips in DMEM, in order to have good cell-substrate attachment. Cell viability was commonly evaluated using a WST-1 cell proliferation assay and an ELISA reader (Dynatech, Chantilly, VA). A Nikon Eclipse Ti-E inverted microscope (Li Trading Co., Taipei City, Taiwan) equipped with 5-megapixel cooled digital camera was commonly used to observe cell growth.
2.3. Intracellular Ca2+ ([Ca2+]i) measurements of MDCK cells
Cells were loaded with 4 μM fura-2/AM (Molecular Probes, Eugene, OR) for 45 min at room temperature (20–25 °C). Changes in [Ca2+]i were monitored with single-cell imaging using a TillvisION imaging system equipped with a Polychrome II high-speed monochromator (TILL Photonics, Martinsried, Germany). Fura-2 was excited sequentially by 340 and 380 nm light delivered from a xenon lamp via a ×40, 1.3 NA UV fluor oil objective (Olympus, Tokyo, Japan). The fluorescent images were collected at 510 nm scale every 0.5 sec by a Peltier-cooled CCD camera. The ratio of fluorescence, R (340 nm/380 nm), from an individual cell was obtained by using TILL visION software 4.0 (Till Photonics) [47].
2.4. Electrophysiological measurements
Shortly before the experiments, a coverslip, on which MDCK cells were grown, was placed on the home-made recording chamber which was mounted on the stage of a CKX-41 inverted fluorescent microscope (Olympus, Tokyo, Japan) coupled to digital video system (DCR-TRV30; Sony, Japan) with a magnification of up to 1500×. The examined cells were immersed at room temperature (20–25 °C) in normal Tyrode’s solution. The electrodes used were pulled from Kimax-51 capillaries (#34500; Kimble Glass, Vineland, NJ) in either a PP-83 puller (Narishige, Tokyo, Japan) or a P-97 Flaming/Brown micropipette puller (Sutter, Novato, CA), and their tips were fire-polished with an MF-83 microforge (Narishige). The pulled electrodes, which commonly had a tip resistance of 3–5 MΩ when filled with different internal solutions described above, were maneuvered using a WR-98 micromanipulator (Narishige). An anti-vibration air table was used to enhance stability during electrophysiological experiments. Patch clamp recordings were obtained in cell-attached, inside-out or whole-cell configuration using an RK-400 (Bio-Logic, Claix, France) or Axopatch 200B (Molecular Devices, Sunnyvale, CA) amplifier [45]. The junctional potentials between the pipette solution and extracellular medium were corrected immediately before seal formation was made.
To induce membrane stretch, membrane tension of MDCK cells was altered by applying negative pressure with a calibrated syringe to the back end of the recording electrode through the suction port of the electrode holder [5]. Negative pressure was monitored with a pressure manometer (PM01R; World Precision Instruments, Sarasota, FL).
2.5. Data recordings and analyses
Data acquisition and analyses were controlled by pCLAMP 10.2 (Molecular Devices). Current signals were low-pass filtered at 1 or 3 kHz. The data were sampled online in an ASUSPRO-BU401LG laptop computer (ASUS, Taipei City, Taiwan) at 10 kHz. With the aid of a digital-to-analog conversion, the voltage profiles with either rectangular or ramp pulses created from pCLAMP 10.2 were utilized to correctly determine current–voltage (I–V) relationships for ion currents (e.g., IK). The digital data achieved during the experiments were appropriately analyzed by various analytical tools, including Origin 8.0 (OriginLab, Northampton, MA), LabChart 7.0 (PowerLab Software; AD Instruments, KYS Technology Co., Ltd., New Taipei City, Taiwan), and custom-made macros built in an Excel 2013 spreadsheet run on Windows 8 (Microsoft, Redmond, WA).
2.6. Single-channel analyses
The amplitudes of single BKCa- or IKCa-channel currents seen in MDCK cells were analyzed by use of pCLAMP 10.2 (Molecular Devices). Multi-gaussian adjustments of the amplitude distributions among channels were commonly created to ensure the existence of single-channel events. The functional independence among channels was verified by comparing the observed stationary probability with the values calculated according to the fitted Gaussian function embedded in pCLAMP 10.2. The channel open probabilities were determined using an iterative process to minimize the x2 values which were calculated as there were an adequately large number of independent observations. Open and closed-time histograms of BKCa channels obtained with or without addition of different Iban concentrations were determined by two-exponential function (i.e., fast and slow components). The single-channel conductance of BKCa or IKCa channels was calculated by a linear regression using mean single-channel amplitudes given at different levels of voltage.
The effect of Iban on the probability of BKCa-channel openings seen in MDCK cells are explained by a state-dependent blocker, because this compound preferentially binds to the open state of the channel according to minimal kinetic scheme:
where α and β are the rate constants for the opening and closing of BKCa channels, k+1 and k−1 are the forward (blocking) and backward (unblocking) rate constants caused by the presence of Iban, and [B] is the Iban concentration. C, O and O × B shown in the scheme indicates the closed (resting), open, and open-blocked states, respectively.
On the basis of this reaction scheme, the blocking and unblocking rate constants, k+1 and k−1, were determined from the slow component in the open time of BKCa channels measured at the level of +50 mV. Blocking and unblocking rate constants were then determined using the relation:
where k+1 and k−1 are respectively derived from the slope and the y-axis intercept at [B] = 0 of the linear regression interpolating the reciprocal time constant (1/τb) versus different Iban concentrations. According to this relation, the linearized plot of 1/τb against [B] (i.e., the Iban concentration) was obtained (Fig. 3A) and the dissociation constant (KD = k−1/k+1) of Iban can be thereafter generated.
To assess effects of Iban on the activation curve of BKCa channels, the channel opening probabilities at the different levels of holding potential were measured. The relationships between the membrane potential and the relative open probability obtained before and after addition of Iban (10 μM) were fitted with a Boltzmann function of the following form:
where (N × P)max measured at the level of +90 mV in the control was the taken to be 1.0, V1/2 is the voltage at which there is half-maximal activation, q the apparent gating charge, F Faraday’s constant, R the universal gas constant, and T the absolute temperature.
2.7. Statistical analyses
Linear or nonlinear curve-fitting to experimental data in this study was carried out by means of either pCLAMP 10.2, Microsoft Excel 2013 or Origin 8.0 (OriginLab Corp.). The data of macroscopic or single-channel currents were presented as the mean values ± standard error of the mean (SEM) with sample sizes (n) representing the cell number from which the data were taken. The paired or unpaired Student’s t-test were initially used for the statistical analyses. Assuming that statistical difference among different groups is necessarily evaluated, post-hoc Duncan multiple comparisons were further implemented. Statistical analyses were performed using the Statistical Package for Social Science 20 (SPSS; IBM Corp., Armonk, New York). A P value of less than 0.05 was considered to indicate statistical difference.
3. Results
3.1. Inhibitory effect of Iban on voltage-gated K+ current (IK) recorded from MDCK cells
In an initial set of electrophysiological experiments, we evaluated the effect of Iban on IK in these cells under whole-cell current recordings. As MDCK cells grown on a coverslip were immersed in normal Tyrode’s solution containing 1.8 mM CaCl2, the IK in response to a 1 s ramp pulse from −100 to +60 mV could be readily elicited at a rate of 0.05 Hz. When cells were exposed to different concentrations of Iban, the IK amplitude elicited by the 1 s long ramp pulse became progressively decreased (Fig. 1). For example, at the level of +40 mV, Iban at a concentration of 30 μM reduced current amplitude by 66.2 ± 2.3% from 785 ± 58 to 265 ± 23 pA (n = 17, P < 0.05). After washout of Iban, IK amplitude at the same level returned to 626 ± 34 pA (n = 11). Similar to Iban effects, paxilline or ketamine effectively suppressed the IK amplitude. Moreover, a further addition of soldium hydrosulfide (NaHS, 100 μM) significantly reversed Iban-induced reduction of IK amplitude elicited by the ramp pulse (Fig. 1B). Paxilline or ketamine are recognized as inhibitors of BKCa channels [11], [43], while NaHS which can release hydrogen sulfide (H2S) was reported to activate the activity of BKCa channels [5]. Chlorotoxin (1 μM), a blocker of chloride channels, exerted no effects on IK in these cells. The observed effect of Iban on macroscopic IK did not appear to involve in the suppression of Cl− channels. As such, the results suggest that Iban has a suppressive effect on IK in these cells.
3.2. Iban suppressed BKCa-channel activity measured from MDCK cells
A considerable mix of different K+ channels could be measured during whole-cell recordings. For this reason, in order to determine how Iban can interact with ion channels to depress IK amplitude, single-channel current recordings were performed. In this set of experiments, cell-attached configuration was made and cells were bathed in high K+ solution containing 1.8 mM CaCl2. As shown in Fig. 2, under our experimental conditions, the activity of BKCa channels can be readily detected, as described previously in different types of cells [5], [24], [41]. As Iban at a concentration of 10 or 30 μM was applied to the bath, channel activity was progressively diminished (Fig. 2). For example, addition of Iban (10 μM) significantly reduced the probability of BKCa-channel openings by 50.1 ± 2.1% from 0.178 ± 0.030 to 0.089 ± 0.015 (n = 18, P < 0.05). Similar to the effect of Iban, paxilline (1 μM) or ketamine (10 μM) applied to the bath was effective at suppressing channel activity. Moreover, in continued presence of 30 μM Iban, further addition of NaHS (100 μM) or PF573228 (10 μM) reversed Iban-mediated inhibition of BKCa channels as evidenced by a significant increase in channel activity to 0.097 ± 0.018 (n = 16, P < 0.05) or 0.103 ± 0.019 (n = 16, P < 0.05), respectively. PF573228 was previously reported to activate BKCa channels [37]. These results indicate that Iban can suppress BKCa-channel activity in a concentration-dependent manner in MDCK cells.
3.3. Inability of Iban to alter single-channel conductance
The next set of experiments was conducted to determine Iban effects on BKCa-channel activity measured at different voltages. Cells were bathed in high-K+ solution, which contained 1.8 mM CaCl2 and the recording pipette was filled with K+-containing solution. The activity of BKCa channels was readily detected at different levels of membrane potential. As expected, when membrane became depolarized, the channel open probability continued to increase [43]. As shown in Fig. 3A, according to an ohmic I–V relation of BKCa channels, no notable difference in the single-channel conductance of these channels recorded from MDCK cells was demonstrated (198 ± 12 pS [control] versus 196 ± 11 pS [10 μM Iban], n = 15, P > 0.05), despite a considerable suppression of BKCa-channel activity during exposure to Iban. It is thus clear from these results that Iban did not have any effects on single-channel conductance of these channels.
3.4. Iban-induced shift in the activation curve of BKCa channels
Another set of experiments was further performed to examine whether there is voltage dependence for the inhibitory effect of Iban on BKCa-channel activity. Fig. 3B shows the activation curve of BKCa channels obtained with or without addition of 10 μM Iban. The relationships between the membrane potentials and the probability of BKCa-channel openings were derived and thereafter fitted to a Boltzmann function described in Materials and Methods. In control, V1/2 = 43.1 ± 1.9 mV and q = 7.1 ± 0.2 e (n = 15), whereas in the presence of 10 μM Iban, V1/2 = 65.2 ± 2.2 mV and q = 7.3 ± 0.2 e (n = 12); therefore, addition of Iban not only produced a decrease in the maximal open probability of BKCa channels, but also significantly shifted the activation curve to a positive membrane potential by approximately 22 mV. In contrast, there was no significant difference in the gating charge of the activation curve between the absence and presence of Iban. These data indicate that, in addition to the reduction of BKCa-channel activity, Iban is able to produce a rightward shift in the activation curve of BKCa channels in MDCK cells.
3.5. Change in the magnitude of Iban-mediated reduction of BKCa-channel activity in different level of internal Ca2+
It was also determined whether Iban can modify the Ca2+ sensitivity of BKCa channels. In this set of experiments, inside-out current recordings were made and different concentrations of Ca2+ in the bath before and after addition of Iban (10 μM) to an intracellular surface of the excised patch was applied. At a given concentration of Iban (10 μM), the magnitude of its reduction in BKCa-channel activity became notably decreased as internal Ca2+ was elevated (Fig. 3C). For example, at the holding potential of +50 mV, Iban (10 μM) reduced the activity of BKCa channels at internal Ca2+ concentration of 0.1 μM by 50%, while it at the same concentration decreased channel activity at internal Ca2+ concentration of 1 μM only by 30%. Therefore, these data indicated that the presence of Iban was able to alter Ca2+ sensitivity of BKCa channels in MDCK cells.
3.6. Evaluation of Iban-induced decrease in the slow component of mean open time of BKCa channels in MDCK cells
Since Iban-induced decrease of BKCa-channel activity tends to arise notably from a reduction in channel open probability rather than the decreased number of active channels, effects of Iban on the kinetic behavior of BKCa channels were further analyzed. As shown in Fig. 4A, in cell-attached patches of control cells (i.e., in the absence of Iban), the distribution of open-time durations of BKCa channels measured at the level of +50 mV was convincingly fit by a two-exponential equations with a mean open time of 2.3 ± 0.1 and 45.6 ± 5.6 msec (n = 12). Particularly, during exposure to 10 μM Iban, the mean duration of the slow components of open-time distribution was drastically shortened. For example, Iban at a concentration of 10 μM significantly decreased the slow component of mean open time to 21.5 ± 2.5 ms (n = 12, P < 0.05), while no significant change in the fast component of mean open time was seen (2.2 ± 0.2 ms [n = 12], P > 0.05). The data can be interpreted to mean that Iban-mediated reduction of BKCa channels is primarily attributable to the shortening of mean open time, despite the fact that it fails to modify single-channel conductance of these channels.
During exposure to Iban, in addition to the decreased probability of BKCa-channel openings, the slow component of mean open time for BKCa channels became shortened. To provide more evidence for Iban-induced reduction of BKCa-channel activity, the time constants for the slow component of mean open time obtain in different Iban concentrations were quantitatively analyzed in this study. Interestingly, the effect of Iban on BKCa channels in MDCK cells were found to result in a concentration-dependent shortening in the slow component of mean open time (Fig. 4B). According to the first-order blocking scheme described in Materials and Methods, the relationship between 1/τb and [B] became linear with correlation coefficient of 0.96 (Fig. 4B). The resultant rate constants of blocking and unblocking perturbed by the presence of Iban were 0.00153 ms−1 μM−1 and 0.0187 ms−1, respectively. Dividing k−1 by k+1 is equal to 12.2 μM, a value for the dissociation constant (KD).
3.7. Effect of membrane stretch on Iban-mediated reduction of BKCa-channel activity
It has been demonstrated that fluid flow or shear force may alter the activity of BKCa channels or [Ca2+]i in renal tubular cells [13], [17], [31]. Previous reports have shown the ability of membrane stretch to enhance BKCa-channel activity [5], [36], [43], [44]. We next determined whether Iban effects on these cells can be altered during different level of membrane stretch. It is noted that as an abrupt suction (−2 or −4 kPa) was applied to the membrane, the probability of BKCa-channel openings became raised (Fig. 5). As such, in MDCK cells, application of membrane stretch can enhance the activity of BKCa channels, although this maneuver actually did not modify single-channel conductance. Findings from these results thus led us to suggest that the BKCa channel may in part account for stretch- or flow-induced cellular effects in renal tubular cells in vivo [31]. As shown in Fig. 5, addition of Iban was found to reduce the probability of BKCa channels taken in these cells. However, the magnitude of Iban-mediated inhibition of BKCa-channel activity did not differ significantly in membrane stretch created with −2, −4 and −6 kPa (Fig. 5B).
3.8. Effect of Iban and oxalate on the activity of BKCa channels
Oxalate was previously reported to interact with Ca2+ in renal tubular cells, and nitrogen-containing bisphosphonates could prevent the formation of calcium oxalate stone [1], [7], [26], [34]. As such, we intended to explore whether the inhibitory effects of Iban and oxalate on these channels can operate to be additive. Of interest, as shown in Fig. 6, Iban (10 μM) produced a reduction of the channel open probability measured at the level of +50 mV; however, a subsequent addition of oxalate (30 μM) did not decrease channel activity further. Oxalate (30 μM) alone significantly reduced the probability of BKCa-channel openings from 0.192 ± 0.015 to 0.082 ± 0.008 (n = 12, P < 0.05). There was no significant difference in the channel open probability between the presence of Iban alone and Iban plus oxalate (0.084 ± 0.009 [n = 13] versus 0.082 ± 0.012 [n = 11], P > 0.05). These results thus indicate that the inhibition action by Iban and oxalate of single BKCa channels in MDCK cells is not additive.
3.9. Inhibitory effect of Iban, TRAM-34, Iban plus DC-EBIO and Iban plus 9-phenanthrol (9-PA) on the activity of intermediate-conductance Ca2+-activated K+ (IKCa) channels in MDCK cells
Earlier work in our laboratory has shown the inhibitory effects of Iban on IKCa-channel activity in RAW 264.7 osteoclast precursor cells [45]. In another set of experiments, we further assessed whether the activity of IKCa channels in MDCK cells can be sensitive to any change in the presence of Iban. As shown in Fig. 7, during cell exposure to Iban at a concentration of 30 and 100 μM, the probability of IKCa-channel openings were drastically decreased, although this compound was unable to modify single-channel amplitude. Similarly, TRAM-34 (3 μM), an inhibitor of IKCa channels, was effective at suppressing the activity of IKCa channels. Iban-induced reduction of IKCa channels was reversed by further addition of either DC-EBIO or 9-phenanthrol. Both DC-EBIO and 9-phenanthrol were reported to activate IKCa channels [8], [35], [45]. Therefore, the present results showing the Iban’s ability to suppress IKCa-channel activities are consistent with our previous report made in RAW 264.7 cells [45].
3.10. Effect of Iban, Iban plus PF573228, and Iban plus DC-EBIO on membrane potential in MDCK cells
To determine whether Iban has any effects on the membrane potential of MDCK cells, a final set of experiments were conducted under current-clamp recordings. Cells, bathed in normal Tyrode’s solution containing 1.8 mM CaCl2, had a resting potential of −58.4 ± 2.6 mV (n = 19). When MDCK cells were exposed to Iban (30 μM), the membrane potential became progressively depolarized to −52.1 ± 2.8 mV (n = 13, P < 0.05) (Fig. 8). Subsequent application of PF573228 (10 μM) reversed Iban-mediated depolarization as evidenced by membrane hyperpolarization back to −56.1 ± 2.4 mV (n = 12, P < 0.05). Similarly, in continued presence of Iban (30 μM), a further addition of DC-EBIO hyperpolarized the cells back to −56.3 ± 2.6 mV (n = 11, P < 0.05). The typical effects of Iban, Iban plus PF573228 and Iban plus DC-EBIO on changes in membrane potential in MDCK cells are illustrated in Fig. 8A. These results reflect that Iban-mediated membrane depolarization seen in MDCK cells can result primarily from its inhibition of BKCa or/and IKCa channels. The inhibitory action on the activity of both BKCa and IKCa channels may cause membrane depolarization, thereby affecting functional activities of renal tubular cells, if this action occurring in native cells is the same as that shown here.
4. Discussion
In this study, the single-channel conductance of BKCa channels measured with the use of 145 mM K+ on both sides of the membrane in MDCK was 198 ± 12 pS (n = 15). This value is similar to those of typical BKCa channels described previously in different cell types [5], [11], but much greater than those of small- or intermediate-conductance Ca2+-activated K+ channels. Moreover, the channel activity presented here is sensitive to stimulation by membrane depolarization, [Ca2+]i and membrane stretch, and it can be blocked by paxilline or ketamine.
A previous study showed that H2S donor could prevent gastric damage caused by alendronate, another bisphosphonate [25]. Consistent with previous studies [5], our results demonstrated the ability of NaHS/H2S to counteract Iban-mediated decrease of both macroscopic IK amplitude and BKca-channel activity recorded from MDCK cells. H2S has been reported to protect the kidney against different forms of injury [16]. Therefore, this volatile molecule may protect the damage by bisphosphonates of renal epithelium through a mechanism linked to activation of BKCa channels.
Numerous reports have demonstrated that ketamine, a recreational drug owing to its anesthetic and hallucinogenic actions, could produce significant nephrotoxicity [4], [6], [12], [33], [39]. In this study, this agent was noted to suppress IK amplitude, and its effect could ascribe from its suppression of BKCa channels as reported previously [11]. Whether ketamine-induced tubular cell necrosis or obstructive uropathy described previously [4], [6], [12], [33], [39] is associated with an inhibition of BKCa channels remain to be further studied. Moreover, the administration of bisphosphonates would potentially exacerbate ketamine-mediated damage, because both agents suppress the activity of BKCa channels in renal tubular cells or smooth muscle cells of a urinary bladder. Meanwhile, in continued presence of Iban, oxalate-induced inhibition of BKCa channels seen in MDCK was abolished, suggesting that these two agents may work through a similar mechanism. Our results are in agreement with a number of studies reporting that bisphosphonates have a preventive role in the formation of calcium oxalate stones [1], [7], [26], [30], [34].
In the present study, the ability of Iban to produce an apparent shift of 22 mV to a positive potential in the activation curve of BKCa channels in MDCK cells was observed without any changes in the gating charge of this curve for the opening of BKCa channels. It is thus possible that its interaction with BKCa channels is not mediated through a direct effect on voltage sensor per se. Unlike its effects on IKCa channels [45], the binding site of Iban is most likely to lie outside of the trans-membrane field. Our results also clearly showed that in MDCK cells, membrane stretch could enhance the activity of BKCa channels, despite inability of this maneuver to alter the single-channel conductance of these channels during such maneuver. The BKCa channel in MDCK cells thus indeed exhibits a mechano-sensitive property as described previously [5], [36], [44], [46]. These data suggest that the BKCa channel may play a role in stretch-, volume- or flow-dependent cellular effects in renal tubular cells in vivo [17], [31]. Iban could decrease the probability of BKCa-channel openings in MDCK cells as well as modify the Ca2+ sensitivity of BKCa channels. The results reflect that this compound can exert its effect via a decrease in the affinity of Ca2+ ions for Ca2+ binding site in the membrane. Therefore, during an increase in tensile strength of renal tubule, membrane depolarization, changes in resting [Ca2+]i, and membrane stretch may synergistically contribute to the opening of BKCa channels enriched in renal tubular cells, which are sensitive to inhibition by Iban or other bisphosphonates.
On the basis of a minimal reaction scheme, the KD value of Iban required for Iban-induced shortening in the slow component of mean open time measured from BKCa channels is 12.2 μM. This value is lower than that used to suppress the activity of IKCa channel in RAW 264.7 cells [45]. Both decreased IK amplitude and membrane depolarization caused by this agent in renal tubular cells can be dependent not only on the Iban concentration, but also on the pre-existing membrane potential, [Ca2+]i, and membrane stretch. The estimated peak of plasma Iban concentration has been reported to reach 5 × 103 ng/ml (around 14 μM) [21]. Additionally, the bisphosphonates like Iban can be virtually taken or even accumulated in renal tubular cells through the process of fluid phase endocytosis [3], [38]. Consequently, the observed effects by Iban on BKCa channels tend to develop during the open state of the channel and may occur at the range of the concentrations achievable in humans.
In this study, we were unable to detect voltage-gated Na+ or Ca2+ currents in MDCK cells. Distinguished from previous reports made in thyroid and breast cancer cells and [20,48], addition of Iban at a concentration of 10 μM did not produce any change in the level of [Ca2+]i in MDCK cells, nor did it enhance BKCa-channel activity. No clear difference in acute nephrotoxicity caused by zolendronate and Iban was reported [18]. Iban at higher concentrations also virtually suppressed the activity of IKCa channels in MDCK cells, and DC-EBIO or 9-phenanthrol counteracted Iban-induced suppression of these channels. Therefore, it seems unlikely that Iban-mediated inhibition of BKCa- or IKCa-channel activity in renal tubular cells results predominantly from sustained elevation of [Ca2+]i.
In renal epithelial cells, K+ recycling is an essential step in the control of trans-epithelial transport. Any activation of KCa channels would enhance K+ recycling, hyperpolarize the membrane potential, and facilitate the transport of other ions (e.g., Na+ and Ca2+ ions) or solutes [24], [40], [41], [44]. In addition to inhibition of farnesyl pyrophosphate synthase [19], the inhibitory effects of Iban on these channels may significantly contribute to the underlying mechanisms by which it and other structurally related bisphosphonates affect functional activities of renal epithelial cells, assuming that similar findings can occur in vivo. Whether the nephrotoxicity caused by chronic treatment with Iban occurring in vivo is linked to its effects on ion-channel activity needs to be further investigated.
Conflict of interest
No conflicts of interest, financial or otherwise, are declared by the author(s).
Acknowledgements
The authors would like to thank Yu-Kai Liao and Ching-An Kao for contributing to part of the earlier experiments. This study was partly supported by National Cheng Kung University (no. 1030101), Tainan City, Taiwan. Hui-Zen Chen received a student fellowship from National Cheng Kung University, Tainan City, Taiwan.
References
- 1.Basok E.K., Basaran A., Atsu N., Yildirim A., Tokuc R. Are new-generation bisphosphonates effective for the inhibition of calcium oxalate stone formation in a rat model? Urol. Int. 2008;81:325–329. doi: 10.1159/000151413. [DOI] [PubMed] [Google Scholar]
- 2.Bergner R., Siegrist B., Gretz N., Pohlmeyer-Esch G., Kränzlin B. Nephrotoxicity of ibandronate and zoledronate in Wister rats with normal renal function and after unilateral nephrectomy. Pharmacol. Res. 2015;99:16–22. doi: 10.1016/j.phrs.2015.04.016. [DOI] [PubMed] [Google Scholar]
- 3.Bergner R., Siegrist B., Kränzlin B., Gretz N., Faust H., Pfister T. Determination of renal tissue ibandronate levels in rats with normal and mildly impaired renal function. J. Pharm. Toxicol. Meth. 2013;68:225–230. doi: 10.1016/j.vascn.2012.12.001. [DOI] [PubMed] [Google Scholar]
- 4.Chen C.L., Cha T.L., Wu S.T., Tang S.H., Tsao C.W., Meng E. Renal infarction secondary to ketamine abuse. Am. J. Emerg. Med. 2013;31(3–5):1153. doi: 10.1016/j.ajem.2013.02.036. [DOI] [PubMed] [Google Scholar]
- 5.Chiang N.J., Wu S.N., Chen L.T. The potent activation of Ca2+-activated K+ current by NVP-AUY922 in the human pancreatic duct cell line (PANC-1) possibly independent of heat shock protein 90 inhibition. J. Pharmacol. Sci. 2015;127:404–413. doi: 10.1016/j.jphs.2015.02.009. [DOI] [PubMed] [Google Scholar]
- 6.Dargan P.I., Tang H.C., Liang W., Wood D.M., Yew D.T. Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice. Clin. Toxicol. (Phila) 2014;52:176–180. doi: 10.3109/15563650.2014.892605. [DOI] [PubMed] [Google Scholar]
- 7.Ebisuno S., Kohjimoto Y., Nishikawa M., Inagaki T., Komura T., Ohkawa T. Effect of etidronate disorium on crystallizations in synthetic urine and calcium oxalate crystal adhesion to Madin–Darby canine kidney (MDCK) cells. Int. J. Urol. 1998;5:582–587. doi: 10.1111/j.1442-2042.1998.tb00416.x. [DOI] [PubMed] [Google Scholar]
- 8.Garland C.J., Smirnov S.V., Bagher P., Lim C.S., Huang C.Y., Mitchell R., Stanley C., Pinkney A., Dora K.A. TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery. Br. J. Pharmacol. 2015;172:1114–1123. doi: 10.1111/bph.12985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Grimm P.R., Foutz R.M., Brenner R., Sansom S.C. Identification and localization of BK-b subunits in the distal neprhon of the mouse kidney. Am. J. Physiol. Renal Physiol. 2007;293:F350–359. doi: 10.1152/ajprenal.00018.2007. [DOI] [PubMed] [Google Scholar]
- 10.Huang C., Pollock C.A., Chen X.M. Role of the potassium channel KCa3.1 in diabetic nephropathy. Clin. Sci. (Lond) 2014;127:423–433. doi: 10.1042/CS20140075. [DOI] [PubMed] [Google Scholar]
- 11.Huang M.H., Lin K.H., Chen S.J., Shen A.Y., Wu F.T., Wu S.N. Effects of ketamine and its metabolites on ion currents in differentiated hippocampal H19-7 neuronal cells and in HEK293T cells transfected with a-hslo subunit. Neurotoxicology. 2012;33:1058–1066. doi: 10.1016/j.neuro.2012.05.006. [DOI] [PubMed] [Google Scholar]
- 12.Huang P.W., Meng E., Char T.L., Sun G.H., Yu D.S., Chang S.Y. ‘Walking-stick ureters’ in ketamine abuse. Kidney Int. 2011;80:895. doi: 10.1038/ki.2011.242. [DOI] [PubMed] [Google Scholar]
- 13.Jan C.R., Chen W.C., Wu S.N., Tseng C.J. Nifedipine: verapamil and diltiazem block shock-wave-induced rises in cytosolic calcium MDCK cells. Chin. J. Physiol. 1998;41:181–188. [PubMed] [Google Scholar]
- 14.Jan C.R., Wu S.N., Tseng C.J. The ether lipid ET-18-OCH3 increases cytosolic Ca2+ concentrations in Madin Darby canine kidney cells. Br. J. Pharmacol. 1999;127:1502–1510. doi: 10.1038/sj.bjp.0702691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kino I., Kato Y., Lin J.H., Sugiyama Y. Renal handling of biphosphonate alendronate in rats. Biopharm. Drug Dispos. 1999;20:193–198. doi: 10.1002/(sici)1099-081x(199905)20:4<193::aid-bdd173>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
- 16.Koning A.M., Frenay A.R., Leuvenink H.G., van Goor H. Hydrogen sulfide in renal physiology, disease and transplantation—the smell of renal protection. Nitric Oxide. 2015;46:37–49. doi: 10.1016/j.niox.2015.01.005. [DOI] [PubMed] [Google Scholar]
- 17.Liu W., Schreck C., Coleman R.A., Wade J.B., Hernandez Y., Zavilowitz B., Warth R., Kleyman T.R., Satlin L.M. Role of NKCC in BK channel-mediated net K+ secretion in the CCD. Am. J. Physiol. Renal Physiol. 2011;301:F1088–F1097. doi: 10.1152/ajprenal.00347.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Luedders D.W., Steinhoff J., Thill M., Rody A., Bohlmann M.K. Lack of difference in acute nephrotoxicity of intravenous bisphosphonates zoledronic acid and ibandronate in women with breast cancer and bone metastases. Anticancer Res. 2015;35:1797–1802. [PubMed] [Google Scholar]
- 19.Luhe A., Kunkele K.P., Haiker M., Schad K., Zihlmann C., Bauss F., Suter L., Pfister T. Preclinical evidence for nitrogen-containing bisphosphonate inhibition of farnesyl diphosphate (FPP) synthase in the kidney: implications for renal safety. Toxicol. In Vitro. 2008;22:899–909. doi: 10.1016/j.tiv.2008.01.006. [DOI] [PubMed] [Google Scholar]
- 20.Ma Y.G., Liu W.C., Dong S., Du C., Wang X.J., Li J.S., Xie X.P., Wu L., Ma D.C., Yu Z.B., Xie M.J. Activation of BKCa channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells. PLoS One. 2012;7:e37451. doi: 10.1371/journal.pone.0037451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Marathe D.D., Marathe A., Mager D.E. Integrated model for denosumab and ibandronate pharmacodynamics in postmenopausal women. Biopharm. Drug Dispos. 2011;32:471–481. doi: 10.1002/bdd.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Markowitz G.S., Fine P.L., Stack J.I., Kunis C.L., Radhakrishnan J., Palecki W., Park J., Nasr S.H., Hoh S., Siegel D.S., D’Agati V.D. Toxic acute tubular necrosis following treatment with zoledronate (Zometa) Kidney Int. 2003;64:281–289. doi: 10.1046/j.1523-1755.2003.00071.x. [DOI] [PubMed] [Google Scholar]
- 23.Mosekilde L., Vestergaard P., Rejnmark L. The pathogenesis, treatment and prevention of osteoporosis in men. Drugs. 2013;73:15–29. doi: 10.1007/s40265-012-0003-1. [DOI] [PubMed] [Google Scholar]
- 24.Najjar F., Zhou H., Morimoto T., Bruns J.B., Li H.S., Liu W., Kleyman T.R., Satlin L.M. Dietary K+ regulates apical membrane expression of maxi-K channels in rabbit cortical collecting duct. Am. J. Physiol. Renal Physiol. 2005;289:F922–F932. doi: 10.1152/ajprenal.00057.2005. [DOI] [PubMed] [Google Scholar]
- 25.Nicolau L.A., Silva R.O., Damasceno S.R., Carvalho N.S., Costa N.R., Aragão K.S., Barbosa A.L., Soares P.M., Souza M.H., Medeiros J.V. The hydrogen sulfide donor, Lawesson’s reagent, prevents alendronate-induced gastric damage in rats. Braz. J. Med. Biol. Res. 2013;46:708–714. doi: 10.1590/1414-431X20133030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Okada A., Ohshima H., Itoh Y., Yasui T., Tozawa K., Kohri K. Risk of renal stone formation induced by long-term bed rest could be decreased by premedication with bisphosphonate and increased by resistive exercise. Int. J. Urol. 2008;15:630–635. doi: 10.1111/j.1442-2042.2008.02067.x. [DOI] [PubMed] [Google Scholar]
- 27.Perazella M.A., Markowitz G.S. Bisphosphonate nephrotoxicity. Kidney Int. 2008;74:1385–1393. doi: 10.1038/ki.2008.356. [DOI] [PubMed] [Google Scholar]
- 28.Pfister T., Atzpodien E., Bohrmann B., Bauss F. Acute renal effects of intravenous bisphosphonates in the rat. Basic Clin. Pharmacol. Toxicol. 2005;97:374–381. doi: 10.1111/j.1742-7843.2005.pto_160.x. [DOI] [PubMed] [Google Scholar]
- 29.Pfister T., Atzpodien E., Bauss F. The renal effects of minimally nephrotoxic doses of ibandronate and zoledronate following single and intermittent intravenous administration in rats. Toxicology. 2003;191:159–167. doi: 10.1016/s0300-483x(03)00257-9. [DOI] [PubMed] [Google Scholar]
- 30.Price P.A., Buckley J.R., Williamson M.K. The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J. Nutr. 2001;131:2910–2915. doi: 10.1093/jn/131.11.2910. [DOI] [PubMed] [Google Scholar]
- 31.Rieg T., Vallon V., Sausbier M., Sausbier U., Kaissling B., Ruth P., Osswald H. The role of the BK channel in potassium homeostasis and flow-induced renal potassium excretion. Kidney Int. 2007;72:566–573. doi: 10.1038/sj.ki.5002369. [DOI] [PubMed] [Google Scholar]
- 32.Sehitoglu I., Tumkaya L., Bedir R., Kalkan Y., Cure M.C., Yucel A.F., Zorba O.U., Yuce S., Cure E. Zoledronic acid aggravates kidney damage during ischemia reperfusion injury in rat. J. Environ. Pathol. Toxicol. Oncol. 2015;34:53–61. doi: 10.1615/jenvironpatholtoxicoloncol.2015012424. [DOI] [PubMed] [Google Scholar]
- 33.Selby N.M., Anderson J., Bungay P., Chesterton L.J., Kolhe N.V. Obstructive nephropathy and kidney injury associated with ketamine abuse. NDT Plus. 2008;5:310–312. doi: 10.1093/ndtplus/sfn054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Senzaki H., Yasui T., Okada A., Ito Y., Tozawa K., Kohri K. Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model. Urol. Res. 2004;32:223–228. doi: 10.1007/s00240-004-0409-7. [DOI] [PubMed] [Google Scholar]
- 35.Shen A.Y., Tsai J.H., Teng H.C., Huang M.H., Wu S.N. Inhibition of intermediate-conductance Ca2+-activated K+ channel and cytoprotective properties of 4-piperidinomethyl-2-isopropyl-5-methylphenol. J. Pharm. Pharmacol. 2007;59:679–685. doi: 10.1211/jpp.59.5.0008. [DOI] [PubMed] [Google Scholar]
- 36.Sheu S.J., Wu S.N., Hu D.N. Stretch-stimulated activity of large conductance calcium-activated potassium channels in human retinal pigment epithelial cells. J. Ocul. Pharmacol. Ther. 2005;21:429–435. doi: 10.1089/jop.2005.21.429. [DOI] [PubMed] [Google Scholar]
- 37.So E.C., Wu K.C., Liang C.H., Chen J.Y., Wu S.N. Evidence for activation of BKCa channels by a known inhibitor of focal adhesion kinase, PF573228. Life Sci. 2011;89:691–701. doi: 10.1016/j.lfs.2011.08.013. [DOI] [PubMed] [Google Scholar]
- 38.Verhulst A., Sun S., McKenna C.E., D’Haese P.C. Endocytotic uptake of zoledronic acid by tubular cells may explain its renal effects in cancer patients receiving high doses of the compound. PLoS One. 2015;10:e0121861. doi: 10.1371/journal.pone.0121861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Wai M.S., Chan W.M., Zhang A.Q., Wu Y., Yew D.T. Long-term ketamine and ketamine plus alcohol treatments produced damages in liver and kidney. Hum. Exp. Toxicol. 2012;31:877–886. doi: 10.1177/0960327112436404. [DOI] [PubMed] [Google Scholar]
- 40.Weling P.A. Regulation of renal potassium secretion: molecular mechanisms. Semin. Nephrol. 2013;33:215–228. doi: 10.1016/j.semnephrol.2013.04.002. [DOI] [PubMed] [Google Scholar]
- 41.Wen D., Cornelius R.J., Sansom S.C. Interacting influence of diuretics and diet on BK channel-regulated K homeostasis. Curr. Opin. Pharmacol. 2014;15:28–32. doi: 10.1016/j.coph.2013.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Woda C.B., Bragin A., Kleyman T.R., Satin L.M. Flow-dependent K+ secretion in the cortical collecting duct is mediated by a maxi-K channel. Am. J. Physiol. Renal Physiol. 2001;280:F786–F793. doi: 10.1152/ajprenal.2001.280.5.F786. [DOI] [PubMed] [Google Scholar]
- 43.Wu S.N. Large-conductance Ca2+-activated K+ channels: physiological role and pharmacology. Curr. Med. Chem. 2003;10:649–661. doi: 10.2174/0929867033457863. [DOI] [PubMed] [Google Scholar]
- 44.Wu S.N., Chen B.S., Hsu C.L., Hsu T.I. The large-conductance Ca2+-activated K+ channels: a target for the modulators of estrogen receptors. Curr. Top. Biochem. Res. 2008;10:93–101. [Google Scholar]
- 45.Wu S.N., Huang Y.M., Liao Y.K. Effects of ibandronate sodium, a nitrogen-containing bisphosphonate, on intermediate-conductance calcium-activated potassium channels in osteoclast precursor cells (RAW 264.7) J. Membr. Biol. 2015;248:103–115. doi: 10.1007/s00232-014-9747-8. [DOI] [PubMed] [Google Scholar]
- 46.Wu S.N., Lin P.H., Hsieh K.S., Liu Y.C., Chiang H.T. Behavior of nonselective cation channels and large-conductance Ca2+-activated K+ channels induced by dynamic changes in membrane stretch in cultured smooth muscle cells of human coronary artery. J. Cardiovasc. Electrophysiol. 2003;14:44–51. doi: 10.1046/j.1540-8167.2003.02040.x. [DOI] [PubMed] [Google Scholar]
- 47.Wu S.N., Wu A.Z., Sung R.J. Identification of two types of ATP-sensitive K+ channels in rat ventricular myocytes. Life Sci. 2007;80:378–387. doi: 10.1016/j.lfs.2006.09.042. [DOI] [PubMed] [Google Scholar]
- 48.Yang D.M., Chi C.W., Chang H.M., Wu L.H., Lee T.K., Lin J.D., Chen S.T., Lee C.H. Effects of clodronate on cancer growth and Ca2+ signaling of human thyroid carcinoma cell lines. Anticancer Res. 2004;24(3a):1617–1623. [PubMed] [Google Scholar]